- Price is above the Trend Line, keeping the weekly tape constructive.
- Activity pressure is positive on the latest completed week.
- Volume is elevated versus the 13-week average, confirming attention.
CJMB
NASDAQ
Week ended 24 Jul 2026
Weekly Investor Report
Callan JMB Inc. Common Stock · Industrials · Integrated Freight & Logistics
Latest close
2.55 USD
109.0%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is 81.8% above the Trend Line and sits at 38.3% of its 52-week range. The latest completed week returned 109.0%, after a 235.5% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 59/100. Near-term considerations: earnings are due in 14d.
Setup score
49
out of 100
Latest Close
2.55 USD
24 Jul 2026
1W Return
109.0%
latest completed week
4W Return
235.5%
short-term follow-through
12W Return
129.7%
quarterly tape
Trend Breadth
11.5%
6 of 52 weeks active
Volume Ratio
5.4x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is weak, so confirmation is not yet broad enough.
- The share remains more than 20% below its 52-week high.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
109.0%
Latest completed week; four-week move 235.5%.
Indicator stack
6/74
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Buy
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
59/100
51 relevant articles in the latest sentiment read.
Event risk
14d
Next report is scheduled for 13 Aug 2026; event risk rises as the date approaches.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 81.8% above the Trend Line and sits at 38.3% of its 52-week range. The latest completed week returned 109.0%, after a 235.5% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 5.4x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
30 Jan
6 Feb
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.1812-week average 0.14
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure2/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.18Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 235.5% over four weeks, 129.7% over 12 weeks, and -46.3% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year6
Trend breadth11.5%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.41Latest activity-pressure read.
Pressure change204.0%Four-week change in activity pressure.
Leadership-7.42Latest relative-leadership reading.
RS change90.3%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.
Factor week 26 Jul 2026
Financial statements through 31 Dec 2025
Field coverage 85%
Model confidence 81%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength70/100Blend of value, momentum, and quality. Underlying universe rank 31; rank 1 is best.
Value59/100Relative valuation strength. Underlying universe rank 42; rank 1 is best.
Quality58/100Profitability and accounting quality. Underlying universe rank 43; rank 1 is best.
Momentum59/100Medium-term price momentum. Underlying universe rank 42; rank 1 is best.
Growth59/100Revenue and earnings growth. Underlying universe rank 42; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- - Price divided by trailing earnings.
- Price / sales
- 2.7x Market value relative to trailing revenue.
- EV / EBITDA
- - Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- -22.4% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 35.7% Gross profit retained from each unit of revenue.
- Operating margin
- -184.8% Operating profit retained from revenue.
- Free-cash-flow margin
- -63.4% Free cash flow generated from revenue.
- Return on invested capital
- -307.5% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- -13.5% Latest one-year revenue growth.
- EPS growth
- - Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- - Latest one-year free-cash-flow growth.
- Piotroski F-score
- 1/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 0.0% Cash dividends relative to market value.
- Buyback yield
- -9.5% Net share repurchases relative to market value.
- Shareholder yield
- -9.5% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- -0.1x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment59/100
Weighted news tone is neutral across 51 relevant articles.
19 positive · 31 neutral · 1 negativePatient CapitalFresh
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Fresh buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings14dNext report is scheduled for 13 Aug 2026; event risk rises as the date approaches.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-54.5%Distance below the 52-week high.
13-week volatility34.0%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
30 Jan
27 Feb
27 Mar
24 Apr
22 May
19 Jun
24 Jul
Weeks higher14 of 2612 weeks finished lower.
Best week+109.0%Week of 24 Jul.
Worst week-44.1%Week of 30 Jan.
Latest week+109.0%Week of 24 Jul.
Shape of recent returns
Strong gains10
Modest gains4
Flat weeks0
Modest losses2
Sharp losses10
Recent vol34.0%13-week weekly-return volatility.
Base vol34.0%52-week weekly-return volatility.
Up/down split23/29Count of positive and negative weeks in the 52-week window.
Average skew21.1% / -12.3%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorUS Industrials
4-week rank- / 100
Group average-0.7%
Trend breadth52.0%
Trend52.0%active weekly trend signals
MD53.0%positive activity pressure
RS56.0%positive relative leadership
Four-week leaders
IndustryUS Integrated Freight & Logistics
4-week rank1 / 28
Group average5.3%
Trend breadth35.7%
Trend35.7%active weekly trend signals
MD57.1%positive activity pressure
RS39.3%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape39/100
Trend, activity pressure, participation, and risk combine to a 39/100 tape read.
Indicator analysis15/100Latest 12-week confirmation: trend 0/12, activity pressure 2/12, relative leadership 0/12.
Activity pressure 0.18; No reversal markers Factors61/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 86 Patient CapitalFreshActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Fresh buy signal Sentiment59/100Weighted news tone is neutral across 51 relevant articles.
Callan JMB Breaks Ground on Marion 9 Biomanufacturing Center at Atlas Complex in Partnership with Alabama State University Insiders50/100No recent insider transaction evidence is stored.
Earnings14dNext report is scheduled for 13 Aug 2026; event risk rises as the date approaches.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 24 Jul 2026 | 2.55 USD | 109.0% | 1.40 USD | 3.20 USD | 0.41 | -7.42 | 57.1M | Off |
| 17 Jul 2026 | 1.22 USD | 59.2% | 1.36 USD | 3.20 USD | 0.10 | -57.37 | 61.9M | Off |
| 10 Jul 2026 | 0.77 USD | -6.1% | 1.37 USD | 3.23 USD | -0.21 | -75.21 | 317.4K | Off |
| 3 Jul 2026 | 0.82 USD | 7.4% | 1.40 USD | 3.26 USD | -0.27 | -74.07 | 297.6K | Off |
| 26 Jun 2026 | 0.76 USD | 5.9% | 1.43 USD | 3.30 USD | -0.40 | -76.43 | 192.8K | Off |
| 19 Jun 2026 | 0.72 USD | -12.6% | 1.49 USD | 3.33 USD | -0.40 | -79.43 | 700.4K | Off |
| 12 Jun 2026 | 0.82 USD | 13.7% | 1.56 USD | 3.37 USD | -0.34 | -76.52 | 5.5M | Off |
| 5 Jun 2026 | 0.72 USD | -1.1% | 1.66 USD | 3.41 USD | -0.36 | -79.52 | 258.6K | Off |
| 29 May 2026 | 0.73 USD | -7.1% | 1.77 USD | 3.44 USD | -0.29 | -80.86 | 216.1K | Off |
| 22 May 2026 | 0.79 USD | -22.2% | 1.87 USD | 3.48 USD | -0.30 | -79.49 | 8.0M | Off |
| 15 May 2026 | 1.01 USD | -11.4% | 1.99 USD | 3.52 USD | -0.46 | -74.23 | 225.0K | Off |
| 8 May 2026 | 1.14 USD | 2.7% | 2.09 USD | 3.56 USD | -0.39 | -71.92 | 223.6K | Off |
| 1 May 2026 | 1.11 USD | 7.8% | 2.20 USD | 3.60 USD | -0.34 | -71.91 | 1.2M | Off |
| 24 Apr 2026 | 1.03 USD | -14.2% | 2.32 USD | 3.64 USD | -0.19 | -74.29 | 348.4K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.